Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$1.39 - $5.58 $4,354 - $17,482
-3,133 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$4.71 - $5.92 $162,108 - $203,754
-34,418 Reduced 91.66%
3,133 $15,000
Q2 2021

Aug 11, 2021

SELL
$5.32 - $6.53 $2,106 - $2,585
-396 Reduced 1.04%
37,551 $205,000
Q1 2021

May 13, 2021

BUY
$2.75 - $6.57 $104,354 - $249,311
37,947 New
37,947 $202,000
Q4 2020

Feb 16, 2021

SELL
$1.38 - $3.01 $10,166 - $22,174
-7,367 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$1.58 - $4.77 $11,639 - $35,140
7,367 New
7,367 $13,000
Q1 2020

May 14, 2020

SELL
$2.33 - $12.98 $20,599 - $114,756
-8,841 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$6.75 - $11.15 $59,676 - $98,577
8,841 New
8,841 $94,000
Q3 2019

Nov 14, 2019

SELL
$8.57 - $10.72 $331,804 - $415,046
-38,717 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$7.58 - $10.0 $689,181 - $909,210
-90,921 Reduced 70.13%
38,717 $317,000
Q1 2019

May 15, 2019

BUY
$5.81 - $9.37 $753,196 - $1.21 Million
129,638 New
129,638 $999,000
Q4 2018

Feb 14, 2019

SELL
$5.75 - $21.85 $1.39 Million - $5.3 Million
-242,443 Closed
0 $0
Q3 2018

Dec 21, 2021

BUY
$16.81 - $24.58 $367,063 - $536,728
21,836 Added 9.9%
242,443 $5.45 Million
Q3 2018

Nov 14, 2018

BUY
$16.81 - $24.58 $210,528 - $307,839
12,524 Added 6.02%
220,607 $4.95 Million
Q2 2018

Apr 21, 2020

BUY
$18.6 - $24.94 $63,816 - $85,569
3,431 Added 1.68%
208,083 $4.01 Million
Q2 2018

Aug 14, 2018

SELL
$18.6 - $24.94 $285,268 - $382,504
-15,337 Reduced 6.97%
204,652 $3.95 Million
Q1 2018

Oct 18, 2019

BUY
$20.86 - $26.6 $60,097 - $76,634
2,881 Added 1.33%
219,989 $5.07 Million
Q1 2018

May 15, 2018

BUY
$20.86 - $26.6 $1.15 Million - $1.47 Million
55,252 Added 34.14%
217,108 $5.01 Million
Q4 2017

Feb 14, 2018

SELL
$20.9 - $49.36 $779,026 - $1.84 Million
-37,274 Reduced 18.72%
161,856 $3.98 Million
Q3 2017

Nov 14, 2017

BUY
$39.62 - $46.17 $7.89 Million - $9.19 Million
199,130
199,130 $8.45 Million

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $599M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.